Daniel Joelsson

Daniel Joelsson is an accomplished R&D Operations and Strategy professional with 25 years of experience in the biopharmaceutical sector. They are currently serving as the Executive Director, Head of Portfolio & Enabling Functions within BioPharmaceuticals Clinical Operations at AstraZeneca, where they lead a diverse team supporting strategic initiatives and operational efficiency. Previously, Daniel held various leadership roles, including Senior Director of Transformation Management and Global Head of Business Operations at AstraZeneca, and Associate Director at MedImmune, where they drove significant process improvements and cost savings. Daniel earned a B.S. in Microbiology Biochemistry/Molecular Biology from The Pennsylvania State University.